A valuable proposition

The ultimate test of any financial instrument is whether it increases the corporate value of its issuer. Does the instrument improve the quality of the issuer’s earnings? Does it improve return on capital? In short, does it make the shareholders richer?

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Alternative Risk Transfer

UK captive regime set for overhaul as regulators seek growth

15 July 2026 PRA and FCA outline new regime with lighter capital, reporting, authorisation requirements.

Alternative Risk Transfer

Market to take off in next two to three years, parametric leaders predict

15 July 2026 Parametric products, along with all traditional insurance offerings, will be traded entirely differently in the coming years, and the resulting landscape could surprise and excite.

Alternative Risk Transfer

Beyond the trigger – a parametric first approach

15 July 2026 Parametric cover should be considered at the start of a placement. Leaving it until last could mean missed opportunities to improve capital efficiency and risk transfer.

Active Re reports 16.1% ROE as disciplined underwriting supports 2025 results

Travelers accelerated in commercial Q2 on mid-market play, margin up

Travelers cuts reinsurance treaty, ups cat bond load

US P&C outlook improves on the back of strong economic, underwriting trends

Allstate escapes second quarter on reduced cat hit

Fewer than half of young luxury buyers insure their collections: Chubb

SiriusPoint creates COO role with former Zurich leader

Mereo joins ABIR as Bermuda reinsurance platform expands presence

A valuable proposition

More on this story

Editor's picks

Editor's picks

More articles